top of page

Leaders of Brandon Capital, a seed and VC firm formed in Australia and with an office in the UK as well, discuss their $290 million sixth fund

blonca9
13 hours ago
1 min read

Founding Partner Stephen Thompson and Partner Jonathan Tobin list some of their recent investments, highlight the advantage of running speedy clinical trials in Australia, and comment on what the benefits to life sciences would be if the UK would allow pensions to invest in private venture funds.

Recent Posts

Michael White, Head of Life Sciences & Healthcare, UK & Nordics at HSBC Innovation Banking, shares insights from his team's UK & Nordics: Life Sciences & Healthcare 1H 2025 Venture Financing Report

Michael White, Head of Life Sciences & Healthcare, UK & Nordics at HSBC Innovation Banking, shares insights from his team's UK & Nordics: Life Sciences & Healthcare 1H 2025 Venture Financing Report

H.C. Wainwright & Co. CEO Mark Kaplan sees a warming up of the fundraising environment for biotech over the coming months

H.C. Wainwright & Co. CEO Mark Kaplan sees a warming up of the fundraising environment for biotech over the coming months

Stanford professor James Zou and his team created a virtual lab with AI scientists - they designed nanobodies for a COVID variant

Stanford professor James Zou and his team created a virtual lab with AI scientists - they designed nanobodies for a COVID variant

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsors

NYSE_logo_large_no reg_378x197 (1).png

Learn more about our sponsors

Sponsor Spotlight

Genezen is a contract development and manufacturing organization (CDMO) with unique technical expertise in lentiviral, retroviral, and adeno-associated viral vectors. Offering process development, GMP viral vector manufacturing, and analytics, we are dedicated to helping you deliver safe, pure, and potent advanced therapies to the patients who need them.

Learn more about Genezen

bottom of page